| Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy F Amor, A Vu Hong, G Corre, M Sanson, L Suel, S Blaie, L Servais, T Voit, ... Journal of cachexia, sarcopenia and muscle 12 (3), 677-693, 2021 | 30 | 2021 |
| miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy M Sanson, A Vu Hong, E Massourides, N Bourg, L Suel, F Amor, G Corre, ... Scientific reports 10 (1), 9139, 2020 | 22 | 2020 |
| 30 Years of Translational Mobility Medicine: 2020 Padua Muscle Days go virtual from Euganean Hills, November 19th to 21st U Carraro European Journal of Translational Myology 30 (4), 2020 | 12 | 2020 |
| Co-administration of simvastatin does not potentiate the benefit of gene therapy in the mdx mouse model for Duchenne muscular dystrophy N Bourg, A Vu Hong, W Lostal, A Jaber, N Guerchet, G Tanniou, F Bordier, ... International Journal of Molecular Sciences 23 (4), 2016, 2022 | 7 | 2022 |
| A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy AV Hong, M Sanson, I Richard, D Israeli European Journal of Translational Myology 31 (3), 2021 | 6 | 2021 |
| Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy AV Hong, N Bourg, P Sanatine, J Poupiot, K Charton, E Gicquel, ... Life Science Alliance 6 (1), 2023 | 3 | 2023 |
| Deciphering the Molecular Mechanism of Incurable Muscle Disease by a Novel Method for the Interpretation of miRNA Dysregulation D Israeli, A Vu Hong, G Corre, Q Miagoux, I Richard Non-coding RNA 8 (4), 48, 2022 | 2 | 2022 |
| Author Correction: miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy M Sanson, A Vu Hong, E Massourides, N Bourg, L Suel, F Amor, G Corre, ... Scientific Reports 14 (1), 7441, 2024 | | 2024 |
| An integrin-targeting AAV developed using a novel computational rational design methodology presents improved targeting of the skeletal muscle and reduced liver tropism AV Hong, L Suel, J Poupiot, I Richard | | 2023 |
| AAV Gene Transfer of Dlk1-Dio3 miRNAs Indicates That the miRNA Cluster Regulates Mitochondrial Activities in Duchenne Muscular Dystrophy AV Hong, N Bourg, P Sanatine, J Poupiot, K Charton, E Gicquel, ... MOLECULAR THERAPY 30 (4), 491-492, 2022 | | 2022 |
| Co-administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy International Journal of Molecular Sciences, 2022 | | 2022 |
| DMD–ANIMAL MODELS: EP. 93 The DLK1-DIO3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in DMD AV Hong, N Bourg-Alibert, P Sanatine, J Poupiot, K Charton, E Gicquel, ... Neuromuscular Disorders 31, S77, 2021 | | 2021 |
| DMD–ANIMAL MODELS: EP. 84 Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy AV Hong, F Amor, G Corre, M Sanson, L Suel, S Blaie, L Servais, T Voit, ... Neuromuscular Disorders 31, S74-S75, 2021 | | 2021 |
| Novel pathological mechanisms support new therapeutic opportunities in Duchenne Muscular Dystrophy AV Hong Université Paris-Saclay, 2021 | | 2021 |
| O. 3MiR-379 link glucocorticoid treatment to mitochondrial dysfunction in Duchenne muscular dystrophy M Sanson, E Massourides, V Mournetas, AV Hong, P Bénit, I Barthélémy, ... Neuromuscular Disorders 29, S38-S39, 2019 | | 2019 |
